These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28815200)

  • 1. The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care.
    Kaul KL; Sabatini LM; Tsongalis GJ; Caliendo AM; Olsen RJ; Ashwood ER; Bale S; Benirschke R; Carlow D; Funke BH; Grody WW; Hayden RT; Hegde M; Lyon E; Murata K; Pessin M; Press RD; Thomson RB
    Acad Pathol; 2017; 4():2374289517708309. PubMed ID: 28815200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics.
    Khatab Z; Yousef GM
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):546-562. PubMed ID: 34297653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostics Reform and Harmonization of Clinical Laboratory Testing.
    Schreier J; Feeney R; Keeling P
    J Mol Diagn; 2019 Sep; 21(5):737-745. PubMed ID: 31075512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the Clinical Laboratory Improvement Amendments of 1988 on cytopathology practice: a 25th anniversary review.
    Davey DD; Austin RM; Birdsong G; Zaleski S
    J Am Soc Cytopathol; 2014; 3(4):188-198. PubMed ID: 31051685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. College of american pathologists proposal for the oversight of laboratory-developed tests.
    Vance GH
    Arch Pathol Lab Med; 2011 Nov; 135(11):1432-5. PubMed ID: 22032569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the impact of a CD4+ T-cell testing laboratory improvement program.
    Rosner E; Siragusa M; Schalla W; Cross D; Cohn R; Hearn T
    Arch Pathol Lab Med; 1998 Jun; 122(6):512-9. PubMed ID: 9625418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice patterns of testing waived under the clinical laboratory improvement amendments.
    Steindel SJ; Granade S; Lee J; Avery G; Clarke LM; Jenny RW; LaBeau KM
    Arch Pathol Lab Med; 2002 Dec; 126(12):1471-9. PubMed ID: 12456207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are physicians' office laboratory results of comparable quality to those produced in other laboratory settings?
    Hurst J; Nickel K; Hilborne LH
    JAMA; 1998 Feb; 279(6):468-71. PubMed ID: 9466642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).
    Todd CA; Sanchez AM; Garcia A; Denny TN; Sarzotti-Kelsoe M
    J Immunol Methods; 2014 Jul; 409():91-8. PubMed ID: 24120573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory precision performance: state of the art versus operating specifications that assure the analytical quality required by clinical laboratory improvement amendments proficiency testing.
    Westgard JO; Bawa N; Ross JW; Lawson NS
    Arch Pathol Lab Med; 1996 Jul; 120(7):621-5. PubMed ID: 8757464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of test systems waived by the Clinical Laboratory Improvement Amendments of 1988. Perceptions and practices.
    LaBeau KM; Simon M; Steindel SJ
    Arch Pathol Lab Med; 2000 Aug; 124(8):1122-7. PubMed ID: 10923070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing for Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) Inspections.
    Zneimer SM; Hongo D
    Curr Protoc; 2021 Dec; 1(12):e324. PubMed ID: 34958716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned: establishing a CLIA-equivalent laboratory for targeted mass spectrometry assays - navigating the transition from research to clinical practice.
    Han CL; Lai CT; Reyes AJ; Yang HC; Lu JY; Shih SR; Chen KY; Hoofnagle AN; Yu SL; Bocik W; Hiltke T; Chiu HC; Wan CY; Rodriguez H; Zhang V; Chen YJ
    Clin Proteomics; 2024 Feb; 21(1):12. PubMed ID: 38389054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical laboratory regulation under the Clinical Laboratory Improvement Amendments of 1988: can it be done?
    Peddecord KM; Hammond HC
    Clin Chem; 1990 Dec; 36(12):2027-35. PubMed ID: 2253342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients.
    Szczepura A; Westmoreland D; Vinogradova Y; Fox J; Clark M
    Health Technol Assess; 2006 Apr; 10(10):1-176. PubMed ID: 16595079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.